A large body of evidence has appeared over the last 6 years suggesting that nitric oxide biosynthesis is a key factor in the pathophysiological response of the brain to hypoxia-ischemia. Whilst studies on the influence of nitric oxide in this phenomenon initially offered conflicting conclusions, the use of better biochemical tools, such as selective inhibition of nitric oxide synthase (NOS) isoforms or transgenic animals, is progressively clarifying the precise role of nitric oxide in brain ischemia. Brain ischemia triggers a cascade of events, possibly mediated by excitatory amino acids, yielding the activation of the Ca 2 -dependent NOS isoforms, i.e. neuronal NOS (nNOS) and endothelial NOS (eNOS). However, whereas the selective inhibition of nNOS is neuroprotective, selective inhibition of eNOS is neurotoxic. Furthermore, mainly in glial cells, delayed ischemia or reperfusion after an ischemic episode induces the expression of Ca 2 -independent inducible NOS (iNOS), and its selective inhibition is neuroprotective. In conclusion, it appears that activation of nNOS or induction of iNOS mediates ischemic brain damage, possibly by mitochondrial dysfunction and energy depletion. However, there is a simultaneous compensatory response through eNOS activation within the endothelium of blood vessels, which mediates vasodilation and hence increases blood flow to the damaged brain area. ß
Introduction
It is well known that the brain is particularly susceptible to interferences with its blood supply [1] . Thus, in the absence of blood £ow, and therefore of oxygen, the energy reserves of the brain are capable of sustaining ATP levels for about 1 min [2] . Since cerebral metabolism depends on a continuous supply of glucose and oxygen, during an asphyctic episode there is a compensative phenomenon aimed at maintaining the brain circulation, and the body is able to compensate for the hypoxemia without compromising vital organs. However, when the asphyxia is prolonged, cerebral blood £ow (CBF) decreases because of the fall in cardiac output, hence becoming a critical factor in the appearance of brain damage [3, 4] .
Although the pathophysiology of the above-mentioned phenomena has been extensively studied, over the last 6 years, much evidence has suggested the involvement of the free radical nitric oxide ( c NO) in control of the physiological responses to brain hypoxia-ischemia. In the present review, we discuss both the neurotoxic and neuroprotective roles of c NO in the ischemic phenomenon, with special emphasis on the biochemical mechanisms through which c NO exerts its interference.
Nitric oxide biosynthesis in the brain
It is now well established that c NO is a physiological messenger in the central nervous system [5] (reviewed by [6] ) and is synthesized by the c NO synthase (NOS)-catalyzed reaction. Activation of this enzyme forms c NO and L-citrulline from L-arginine [7, 8] , thus participating in the transduction pathway leading to elevations in intracellular cyclic GMP levels [9, 10] .
Whilst the precise role of c NO production in the brain remains to be fully elucidated, it seems that this free radical is involved in important functions, such as the regulation of the CBF or memory (for reviews, see [11^13] ). Thus, activation of NOS within the endothelial cells produce c NO, which di¡uses to the neighboring smooth muscle cells and activates guanylate cyclase. The increase in cyclic GMP causes smooth muscle relaxation and thus vasodilation [14] . Within the brain, the cerebellum is an important site for c NO production after activation of NOS enzyme [15] and all brain cells have now been shown to be able to synthesize c NO (reviewed in [16, 17] ) following di¡erent types of stimulus.
At least three isoforms of NOS have been characterized in brain cells. Neurons produce c NO mainly by Ca 2 -dependent activation of neuronal NOS (nNOS or NOS1), which is constitutively expressed in these cells [8] . In contrast, glial cells (astrocytes, microglia and oligodendrocytes) synthesize c NO mainly after calcium-independent inducible NOS expression (iNOS or NOS2) by treatment with the endotoxin lipopolysaccharide (LPS) and/or certain cytokines, such as interferon-Q, tumor necrosis factor-K or interleukin-1L (for reviews, see [16^18] ; see also [19] ). Finally, endothelial cells produce c NO by the constitutive, Ca 2 -dependent activity of endothelial NOS (eNOS or NOS3) [8] . In addition to this commonly accepted distribution, it should be mentioned that most brain cell types are able to express several NOS isoforms. Thus, astrocytes are known to produce c NO via the constitutive nNOS activity [20^23] and both endothelial cells [24] and neurons [25] express iNOS after lipopolysaccharide plus cytokines treatment.
Excess nitric oxide biosynthesis may be neurotoxic
Under certain pathological conditions, nNOS activation might be exacerbated and the excess c NO thus formed becomes neurotoxic [26^28] and may play a role in neurodegeneration (e.g. see the reviews [293 2]). The mechanism leading to excessive nNOS activation is thought to be mediated by the hyperactivation of glutamate receptors, especially the N-methyl-D-aspartate (NMDA) subtype, in the postsynaptic neuron, which leads to increased intracellular free Ca 2 , subsequent nNOS activation [28] and, possibly, mitochondrial dysfunction and cell death [33] . In addition, several stimuli, most of them involving cytokine-mediated gene expression activation, strongly induce iNOS expression in glial cells, allowing massive and uncontrolled c NO release by these cells; this may be damaging for the neighboring neurons [17, 34] .
The mechanism through which excess c NO formation within the brain leads to neuronal death involves energy depletion, lipid and protein peroxidation, protein nitrosylation and DNA damage (reviewed in [32] ). Furthermore, whereas the c NO species has been shown to cause some cell damage in vitro, increasing evidence suggests that the endogenous formation of peroxynitrite anion (ONOO 3 ), from the reaction of c NO with O c3 2 [35, 36] , may be a possible mechanism through which neurotoxicity is induced. The relevance of these mechanisms for c NOmediated brain damage in hypoxia-ischemia will be discussed below.
Nitric oxide biosynthesis is increased by ischemia

Neuronal production of c NO in ischemia
Despite the evidence suggesting excessive c NO biosynthesis due to ischemic injury, direct experimental evidence showing enhanced c NO biosynthesis in the brain in vivo has emerged from electron paramagnetic resonance (EPR) spectroscopy with spin-trapping agents after freezing tissue samples from bilateral carotid occlusion or focal ischemia of the rat brain. The signal increased according to the degree of the ischemic insult [37, 38] and during reperfusion if ischemia was greater than 15 min [39] and disappeared following administration of the NOS inhibitor L-N g -nitro-L-arginine methyl esther (L-NAME) [40] . Other studies have subsequently con¢rmed and expanded the notion that brain c NO biosynthesis is increased by ischemic insult. With the EPR spectroscopy technique, nitrosyl hemoglobin due to the ischemic episode has been only weakly detected, but is strongly detected after reperfusion [41] , suggesting that oxygen recovery enhances c NO synthesis. In in situ imaging of the EPR signal, c NO has been selectively detected in certain brain areas, such as the cortex, hippocampus, hypothalamus, amygdala and substantia nigra during ischemic episodes [42, 43] . In a study using a c NO microsensor, the ischemia produced by middle cerebral artery (MCA) occlusion increased L-NAME-inhibitable c NO concentrations in the ischemic tissue [44] , pointing to a correlation between the degree of hippocampal CA1 sector injury and c NO [45] . Other indirect methods have also provided evidence for c NO production within the ischemic brain, such as increased concentrations of the c NO-decomposition product nitrite (NO 3 2 ) in dialysates from in vivo microdialysis in the striatum after common carotid artery occlusion [46] . In a rat MCA occlusion model, NO 3 2 and cyclic GMP levels increased sharply after 20 min of ischemia, but NO 3 2 levels returned to basal values after 60 min, a pattern that correlated well with the 10-fold increase in NOS activity [47] . Finally, an L-NAME-inhibitable increase in cyclic GMP has also been observed in the hypoxemic rabbit [48] .
Increased expression of nNOS mRNA in ischemic lesions has also been detected in the rat as early as 15 min after MCA occlusion [49] or after prolonged hypoxia [50] , although in the latter study, eNOS mRNA expression decreased and GTP-cyclohydrolase-I mRNA expression (the rate-limiting step in the biosynthesis of tetrahydrobiopterin, a NOS cofactor) increased. Importantly, the nNOS mRNAcontaining neurons remained undamaged [49] , suggesting that c NO-releasing neurons are resistant to ischemic injury. Similar results were found using nNOS antibodies in 7-day-old rats subjected to 24 h of hypoxia, where the number of nNOS-positive neurons close to the neuronal injury degeneration area increased as from early stages of the hypoxic episode [51] , strongly suggesting a possible role of c NO in the accompanying neurodegeneration.
Finally, NOS activity has been measured in the brain of animals subjected to hypoxia and reoxygenation. In piglets, cytosolic NOS activity decreased during hypoxia [52, 53] , but increased after reoxygenation [53] . Similarly, after 2 h of focal ischemia in mice followed by recirculation, there was a rapid decrease in constitutive NOS activity in the infarcted cortex, but an increase in Ca 2 -independent NOS activity (re£ecting iNOS) and the NO was observed during reperfusion [54] . In another study, increased nNOS-immunopositive neurons were observed after 37 days of hypoxia in the CA3, but not the CA1 hippocampal region of the rat brain, and low doses of the NOS inhibitor N g -nitro-L-arginine (L-NNA) decreased the number of damaged neurons [55] . However, no iNOS protein was detected in this study.
Glial production of c NO in ischemia
Although some studies have failed to show increased Ca 2 -independent NOS activity in the rat MCA occlusion model [56] , substantial evidence now strongly suggests that glial cells may be important sites for c NO production in ischemia. Thus, transient global ischemia causes an early expression of NADPH-diaphorase activity [57, 58] and iNOS immunoreactivity [59] in reactive astrocytes (but not microglia), which in turn may release toxic amounts of c NO and, possibly, cause neuronal damage. In vitro models of hypoxia-ischemia have also revealed the expression of iNOS mRNA, protein expression and enzyme activity in cultured glial cells [60] and in brain slices [61] . Interestingly, in the latter study, iNOS protein was immunohistochemically localized not only in astrocytes, but also in neurons and microglial cells [61] . There is now a strong body of evidence suggestive of iNOS overexpression in glial cells in vivo due to ischemic insults. Thus, in the rat MCA occlusion model, Iadecola and co-workers reported increases in Ca 2 -independent activity accompanied by glial ¢brillary acidic protein (GFAP)-positive cells in the infarcted areas [62, 63] . Moreover, cerebral damage was prevented by the selective iNOS inhibitor aminoguanidine [64, 65] , strongly suggesting a role for glial-derived c NO in ischemic damage. Similar results have been observed using histochemically detected NADPH-diphorase activity and GFAP antibody [66] . Finally, in a study of the regional distribution and levels of NOS protein in the brain of stroke-prone spontaneously hypertensive rats, considerable NOS immunoreactivity was found in reactive astrocytes and microglial cells in the vicinity of the lesions [67] , suggesting that the c NO generated by glial cells might contribute to the development of hypertensive cerebral lesions.
4.3.
c NO production by brain endothelial cells in ischemia Brain endothelial cells have also been shown to increase c NO production in ischemia. In the rat MCA occlusion model, eNOS has been detected immunohistochemically in cerebral vessels in the ischemic region [68] . In cerebral vessels, a 3^7-fold increase in Ca 2 -dependent NOS activity was observed after 2^7 days of ischemia in the same model, although Ca 2 -independent NOS activity was also present after the ¢rst day of ischemia [69] . However, in a study carried out in the monkey subarachnoid hemorrhage model, while eNOS mRNA expression was seen to be decreased in cerebral arteries, it increased in neural tissue [70] . The authors suggest that the decrease in arterial eNOS might be responsible for the vasospasm while increased neural eNOS might be a compensatory mechanism against ischemia. Despite the latter work, most studies have suggested increased eNOS activity during ischemia. Thus, in rats [71] or in piglets [72] , transient global cerebral ischemia is accompanied by enhanced eNOS immunoreactivity in the blood vessels of the hippocampus and it has been suggested that the c NO produced by this mechanism may have neuroprotective e¡ects due to a possible improvement in CBF (see below). Finally, the presence of in vivo induction of iNOS in vascular cells has also been observed in the rat MCA occlusion model [73] . In this study, iNOS mRNA expression and protein immunohistochemical localization were maximal after 12 h of ischemia, but immunoreactivity was restricted to the walls of capillaries and larger blood vessels after 12^24 h [73] .
Neurotoxic versus neuroprotective roles of nitric oxide synthesis in ischemia
Early studies carried out to elucidate whether c NO protects or damages the brain during ischemia yielded con£icting conclusions (e.g. see [74^78] versus [79^81]). Although this discrepancy could be attributed to di¡erences in the experimental animal species used [82] , the use of selective NOS inhibitors or transgenic animals now suggests that in fact c NO can be either neuroprotective or neurotoxic, depending on the cell type from which it is released (neuronal, glial or endothelial) and the length and severity of the ischemic insult (see Fig. 1 ). This issue has recently been reviewed [83^86].
Neurotoxicity of c NO in brain ischemia
Through measurements of the volume of the infarcted area after cerebral ischemia, many studies have demonstrated the protective e¡ect of NOS inhibitors. Thus, L-NNA or L-NAME protected against cerebral damage in rats [87^96], cats [97] and gerbils [98, 99] subjected to MCA occlusion. Although some studies have failed to demonstrate Fig. 1 . Neuroprotective versus neurotoxic e¡ects of nitric oxide in hypoxia-ischemia. Both neuroprotective and neurotoxic effects have been reported when NOS inhibitors are used during brain hypoxia-ischemia. A possible explanation for these con£icting hypotheses is that, whilst ischemic-mediated activation of nNOS in neurons leads to neuronal cell death, activation of eNOS in endothelial cells is neuroprotective. Neuroprotection may occur because the c NO formed in endothelial cells produces relaxation in adjacent smooth muscle cells, thus leading to vasodilation and increased cerebral blood £ow to the ischemic brain region. In addition, induction of iNOS expression in astrocytes occurs after ischemic episodes. The precise consequences of the latter phenomenon are not known, but it has been suggested that the excess c NO formed by this way may be both neurotoxic and neuroprotective. Thus, astrocyte-derived c NO may be neurotoxic because it interferes in neuronal energy metabolism as described in Fig. 2 , but it may also be neuroprotective because it may produce relaxation in neighboring smooth muscle cells.
improvements in CBF distribution due to NOS inhibitors [89, 97, 100] , other groups have reported increases in CBF [101, 102] . The most susceptible brain region to ischemic-mediated c NO injury seems to be the CA1 area of the hippocampus, possibly because it receives a large vascularization, where L-NNA exerts maximal protection [98, 103, 104] . Within this region, a selective loss of NADPH diaphorase-containing neurons occurs [105] , in contrast to the idea of NOS-positive neurons being less vulnerable to c NOmediated injury [27] .
There seems to be a time-dependent neuroprotection of NOS inhibitors against ischemic damage. Thus, in a rat model of focal ischemia, L-NAME exerted better protection during the early stages of the ischemic insult [106] . By contrast, other authors have reported protection by NOS inhibitors during postischemic episodes [102] . In this context, choice of the NOS inhibitor seems to be relevant in preventing c NO-mediated ischemic injury. Thus, the selective in vivo nNOS inhibitor 7-nitroindazole (7-NI), but not the unselective L-NNA, was protective against cerebral infarction in the MCA or bilateral occlusion models [107, 108] . Furthermore, prehypoxic treatment with 7-NI prevented c NO production during hypoxia and reoxygenation, but aminoguanidine (selective iNOS inhibitor) only prevented c NO production during re-oxygenation [109, 110] . These results strongly suggest di¡erent roles for constitutive and inducible nitric oxide synthases in the development of ischemic brain damage. Neuronal production of c NO seems to occur during the early ischemic period, which is followed by delayed glial c NO production.
Glial cells in ischemic-mediated c NO neurotoxicity
A phenomenon observed after brain ischemia is the appearance of reactive astrocytes [111] , as measured by the increased number of GFAP-reactive cells and the increase in local cerebral glucose utilization [112] . A population of these GFAP-positive cells, formed by astrocytes, but not by microglial cells [58] , also expresses iNOS [57, 59] . Interestingly, spreading depression, which confers increased neuronal susceptibility to ischemic damage, induces nNOS (neuronal) protein expression in astrocytic cells [113] , supporting a potential role for glial cells in ischemic neurotoxicity. However, the exact mechanism of this ischemic-mediated astrocyte activation is not well understood. Whereas iNOS induction in astrocytes has been purported to be a consequence of ischemic-mediated neuronal damage [58] , it has also been suggested that neuronal damage after hypoxia/ ischemia episodes may be due to excessive c NO formation by reactive astrocytes [57, 59] . Therefore, whether the induction of iNOS in glial cells is a consequence or a cause of the neuronal degeneration observed after ischemia remains to be discovered.
Brain ischemia, c NO and immunity
Although there is evidence suggesting a role for cytokines and growth factors as mediators of ischemic-mediated iNOS induction in glial cells and neurotoxicity [114, 115] , increasing evidence now suggests that the cytokines and growth factors released by glial cells might be neuroprotective against brain ischemia [116, 117] . In this sense, in cultured rat astrocytes, hypoxic episodes followed by re-oxygenation increased the release of interleukin-1 [118] . Furthermore, basic ¢broblast growth factor, epidermal growth factor or insulin-like growth factor in vitro [119, 120] , and glial-derived neurotrophic factor in vivo [121] and pretreatment of transforming growth factor-L1 before an ischemic insult in vivo [122] have all been shown to prevent hippocampal neurons against c NO neurotoxicity. The role of ischemicmediated iNOS induction in glial cells has been reviewed elsewhere [123^126].
Neuroprotection by c NO in brain ischemia
In several models of brain ischemia, several studies have reported results apparently in contradiction with the generalized notion of a neurotoxic role for ischemic generated c NO. These include the work carried out in gerbils [127, 128] and in rats [79, 81, 129] showing an enhancement of the infarcted area through the inhibition of NOS activity by L-NNA or L-NAME. In experiments in which cerebral blood volume and the infarcted region were monitored [130] , it was reported that NOS inhibition prevents the vasodilation caused by ischemia, suggesting that increased c NO production during ischemia would be protective because it modulates the CBF. Now, much evidence strongly suggests that the control of CBF by excess release of c NO during, and especially after, ischemic episodes may have a bene¢cial role.
Endothelial cells in ischemic-mediated c NO neuroprotection
The protective role of c NO during ischemia may be due to the vasodilation (due to the c NO-mediated raise in cyclic GMP) and by the c NO-mediated inhibition of microvascular plugging by platelets and leukocytes, hence causing the increase in CBF by this free radical [14, 131] . In fact, administration of c NO donors to ischemic MCA-occluded rats improved CBF and reduced ischemic-mediated cerebral infarction [132^135]. This is supported by the observation that infusion of L-arginine (the substrate for c NO biosynthesis) increases regional CBF, preventing both necrotic damage in the rat MCA occlusion model [136, 137] and decreases in brain ATP and glucose levels in the spontaneously hypertensive rat [138] .
Interestingly, in gerbil the degree of NOS inhibition seems to play an important role in modulating ischemic-mediated brain damage [139] . In this study, low doses of L-NNA administration prevented, and high doses potentiated, ischemic-mediated neuronal degeneration [139] , suggesting that during ischemia a small amount of c NO is bene¢cial to brain tissue, whereas an excessive amount of c NO causes neurotoxic e¡ects. Further evidence has suggested that both the neuroprotective and neurotoxic e¡ects of c NO during ischemia could be due to the di¡erent source of c NO under these circumstances. In a recent study [140] , postischemic c NO concentrations were manipulated by using combinations of both L-NAME (an unselective NOS inhibitor) and 7-NI (a selective nNOS inhibitor) in experimentally induced thromboembolic stroke in the rat. It was observed that 7-NI protected against and L-NAME potentiated hippocampal neuronal injury, suggesting that while enhanced nNOS activity during ischemia is neurotoxic, the increase in endothelial eNOS activity would be bene¢cial [140] . In the same ischemic model, L-NAME protected against platelet accumulation and hemodynamic depression [141] , suggesting that these phenomena may account for the cognitive and sensory-motor de¢cits observed in this animal model. Finally, in the MCA occlusion model, NOS inhibition with L-arginine analogs potentiated cerebral infarction due to ischemia in the rat [142] , piglet [143] , lamb fetus [144] , cat [145] and dog [146] . However, this potentiation was prevented by the infusion of either L-arginine or the nNOS inhibitor 7-NI [142] . Furthermore, L-arginine administration [142] or hemoglobin removal by £uorocarbon administration in the perfusates [147] produces vasodilation, leading to increased CBF and an improvement in electrocorticogram activity. These results support the notion that during ischemia, neuronal-derived c NO is neurotoxic, whereas endothelial-derived c NO is bene¢cial, due to the increase in CBF and, therefore, in the oxygen and substrate supply to the insulted brain area.
Whether the vasodilator e¡ects of endothelial-derived c NO in brain ischemia are mediated by cyclic GMP is not known, although early in vivo evidence has suggested that this would be the case [148] . In a recent study of an in vitro model of the blood^brain barrier, O c3 2 scavenging proved to be protective after a hypoxic insult [149] , which suggests that O c3 2 might be neurotoxic because it reacts with c NO to form ONOO 3 . Nevertheless, the hypothesis that c NO would regulate CBF during anoxia has been questioned since it has been reported that acetylcholinemediated c NO enhancement in a reptile and in a teleost increases CBF by a L-NAME-inhibitable process. However, anoxic-induced CBF enhancement could not be blocked by L-NAME [150, 151] . The length of the ischemic insult appears to determine the degree of contribution of c NO to cerebral damage, although the results obtained so far are controversial [152, 153] .
Hypercapnia is thought to mediate vasodilation, although the precise mechanism of this is still unknown. Initial studies a¡orded contradictory results about the involvement of c NO in hypercapnic-mediated vasodilation. Thus, whereas in an MCA occlusion model in the goat L-NAME did not prevent hypercapnic-mediated vasodilation [154] , in a similar model, the same compound prevented vasodilation due to hypercapnia, but not to hypoxia [155, 156] . Moreover, the L-NAME-mediated attenuation of CO 2 -induced vasodilation could be reversed by either a c NO donor (SIN-1, 3-morpholinosydnonimine) or the cyclic GMP analog 8-bromo-cyclic GMP [157] , strongly supporting the notion that a certain level of c NO is essential for the maintenance of the smooth muscle relaxation necessary for vasodilation during hypercapnia.
Hypothermia and c NO-mediated neuroprotection in ischemia
Many studies now suggest that mild hypothermia is neuroprotective against cerebral ischemic damage. Furthermore, it appears that the protective role of hypothermia might be related to its capacity to prevent elevations in c NO levels [158, 159] and neuronal degeneration [160^162]. The precise mechanism of this neuroprotective role still needs clari¢cation, but it should be mentioned that a potential role for glial cells has been reported. In this sense, hypothermicmediated suppression of microglial activation has been observed [163] , possibly suggesting that inhibition of glial-derived c NO by cold treatment would be bene¢cial for the ischemic brain.
Brain ischemia, c NO and acidosis
Inhibition of NOS activity prevents the decrease in intracellular pH in a brain focal ischemia model in rabbits [164, 165] , suggesting a c NO-mediated process in the phenomenon of ischemic acidosis.
Studies in transgenic animals
The development of transgenic animals has o¡ered a powerful tool for the study of the consequences of cerebral ischemia. Mice lacking all known isoforms of c NO synthases have now been used to study the e¡ects of cerebral ischemia. It has been shown that nNOS-de¢cient mice are less vulnerable to hippocampal neuronal damage (usually measured as the volume of infarcted area) after transient or permanent ischemia in the MCA occlusion model [1661 70] . Interestingly, eNOS-transgenic mice are highly vulnerable to cerebral ischemia [171] . These works support the notion that while neuronal-derived c NO during ischemia is neurotoxic, endothelial-derived c NO is neuroprotective, possibly because of the improvement in CBF. Finally, the null mutation of the iNOS gene in mice prevents delayed neurotoxicity caused by brain ischemia [172] , in agreement with the idea that delayed c NO release by ischemic-mediated induction of iNOS expression might be responsible for the toxicity of prolonged ischemia.
Other reports have used mutations in superoxide dismutase (SOD)-encoding genes, allowing study of the O c3 2 radical in ischemic brain injury. Thus, Cu/ Zn^SOD-overexpressing transgenic mice show increased brain injury after perinatal hypoxia-ischemia [173] . Since the overexpression of SOD might increase H 2 O 2 and/or c NO accumulation, the results suggest an involvement of these compounds in the mechanism of neurotoxicity. On the other hand, Mn^SOD-de¢cient transgenic mice are more susceptible to cerebral damage [174] . The exact role of SOD in ischemic brain damage therefore remains obscure (see review [175] ).
5.9.
c NO and memory in the ischemic brain So far, reports about the role of c NO generated during brain ischemia in memory loss have been contradictory. In an in vivo rat model aimed at quantifying the number of errors committed in a working memory task, inhibition of NOS activity by L-NAME by intrahippocampal administration prevented the increase in errors caused by 5 min of ischemia [176] . This suggests a role for c NO in memory loss after ischemia. In contrast, in vitro, speci¢c nNOS inhibitors (7-NI) prevented the long-term potentiation caused by anoxia in CA1 hippocampal neurons [177] . Although other mechanisms can be involved in c NO-dependent anoxic-induced potentiation not linked with memory processes, further research in this ¢eld would evidently be appropriate in order to fully clarify the precise role of c NO in memory loss after anoxia.
The role of nitric oxide and excitatory amino acids in the ischemic brain
It is well known that brain hypoxia-ischemia leads to an increase in the extracellular concentration of glutamate [178, 179] and that excitatory amino acids, such as glutamate, induce degenerative changes in nervous tissues that mimic those produced by hypoxia [180, 181] . In addition, enhanced nNOS gene ex-pression may be achieved by ischemia through a mechanism involving NMDA-receptor activation [182] , although the precise relevance of this observation remains to be elucidated. Furthermore, NMDA glutamate subtype receptor antagonists protect neurons from hypoxia-mediated neurotoxicity [183, 184] . Since c NO at least partially mediates NMDA-dependent neurotoxicity [26] , the role of c NO in NMDA-mediated ischemic brain injury has been advanced (reviewed in [30, 31] ). However, this remains controversial, as discussed below. Early studies disclosed in vivo protection by the NMDA-receptor antagonist MK-801 in brain infarction after MCA occlusion ischemia in the mouse [74] and suggested the involvement of neuronal c NO in the process. In vitro work has shown that CA1 hippocampal neurons are particularly susceptible to c NO-mediated ischemic damage through a process mediated by excess glutamate receptor activation [185] . Hypoxic/ischemic-mediated glutamate^cNO toxicity is potentiated by glucose depletion [186] or by neuronal exposure to astrocyte-derived c NO [187] , suggesting that neuronal de-energization increases susceptibility to NMDA-mediated ischemic damage. This is in agreement with the hypothesis that early anoxic depolarization leading to the release of Ca 2 from intracellular stores might be responsible for subsequent nNOS activation and toxicity [188, 189] , although further experiments aimed to fully clarifying the precise mechanism of nNOS activation in ischemia are warranted.
Despite the above-mentioned evidence, a number of studies have failed to show the potential role of c NO in NMDA neurotoxicity [190^193] or in NMDA-mediated ischemic neurotoxicity [194^196] . Whether this discrepancy can be attributed to the redox cell status and hence NMDA receptor activity modulation [197] remains to be established. Nevertheless, the involvement of c NO in glutamate release by brain cells exposed to ischemic injury has been disregarded [198^200], and a role for adenosine receptor activation in astrocytes may reproduce the neurotoxic e¡ects of ischemia by an c NO-mediated mechanism not involving neuronal glutamate receptors in hippocampal slices [201] . It appears that metabotropic, rather than ionotropic, glutamate-receptor subtype activation leading to c NO production in ischemia may be responsible for this neuroprotective role [202] . Surprisingly, more and more evidence is now suggesting that NMDA-receptor activation leading to c NO production during ischemia may also be neuroprotective. Thus, the c NO formed in neurons by NMDA activation reaches neighboring arterioles, where it elevates cyclic GMP, hence producing vasodilation, possibly mediated by opioids [203] , and improving regional CBF [204^206].
Peroxynitrite and brain ischemic damage
The scavenging of oxygen-derived free radicals prevents neurotoxicity due to the excess c NO formed during ischemia [207, 208] and during NMDA receptor activation [209^211]. These observations strongly suggest the involvement of endogenous peroxynitrite (ONOO 3 ) formation, leading to neuronal degeneration after ischemic, glutamate-mediated activation of nNOS [77, 212, 213] . The in situ production of ONOO 3 has been detected by chemical [214] and immunohistochemical [215] determinations of 3-nitrotyrosine, a compound thought to be speci¢cally accumulated by the action of ONOO 3 . Since ONOO 3 is a strong pro-oxidant compound [35, 36] , lipid peroxidation is another possible feature of endogenous ONOO 3 formation. In this sense, brain lipid peroxidation and membrane dysfunction have been observed in in vivo hypoxia, pointing to ONOO 3 as the origin of such e¡ects [216^218]. Finally, SOD-overexpressing transgenic mice are highly resistant to ischemic brain damage [219] and display strongly suppressed ONOO 3 production, lipid peroxidation, and considerable mitochondrial dysfunction [220] , suggesting a potential role for ONOO 3 in c NO-mediated ischemic brain injury.
Mechanisms for nitric oxide-mediated brain damage
The most widely accepted ischemic perturbation that culminates in brain damage is the uncoupling of oxidative phosphorylation [221] . This phenomenon is characterized by the inability of mitochondria to generate energy in the form of ATP. Instead, any energy that is produced by the mitochondrial respiratory chain is dissipated as heat [222] . The observa-tion that an increased cerebral metabolic rate for glucose runs concomitant with decreased cerebral energy utilization has con¢rmed that the decrease in ATP concentrations occurring during the recovery phase is due to the uncoupling of mitochondrial oxidative phosphorylation (Fig. 2) [223^225].
Mitochondrial dysfunction and
c NO in brain ischemic damage
The precise mechanism responsible for mitochondrial dysfunction due to hypoxia-ischemia in the brain is not fully understood. Initial evidence came from studies suggesting that a loss of respiratory control [226, 227] , a decline in ATP synthesis, and mitochondrial swelling and enhanced lipolysis of mitochondrial membranes occur in these circumstances [228, 229] . Mitochondrial respiration and the mitochondrial respiratory chain seem to be especially susceptible to hypoxia-ischemia and reperfusion. Thus, during brain ischemia complexes I and II^III of the mitochondrial respiratory chain are damaged in both the rat [230] and the gerbil [231] . However, although the activity of complex IV is not a¡ected by ischemia [231, 232] , it is strongly inhibited after a long period (120 min) of reperfusion [232, 233] , suggesting irreversible damage to this complex, possibly due to free radical production and lipid peroxidation. Interestingly, complex IV activity, together with that of complex II^III are the most susceptible components of the mitochondrial respiratory chain to irreversible damage due to excess c NO production in brain cells [33, 234] (for a review, see [32] ). Moreover, the brain activity of these complexes is severely damaged in the brain of neonates subjected to 5 min of anoxia. However, inhibition of brain NOS activity by L-NAME administration to the mothers prevented this mitochondrial damage [235] , strongly suggesting that mitochondrial dysfunction during brain ischemia may be a c NO-mediated process.
c NO-mediated poly(ADP-ribose) synthesase activation in brain ischemia
Brain ischemic damage is prevented by inhibitors of poly(ADP-ribose) synthesase [236] and in transgenic mice lacking poly(ADP-ribose) polymerase [237] . Since the increase in the activity of this energy-consuming pathway is believed to mediate c NO neurotoxicity [238] , this mechanism may contribute to c NO-mediated cerebral damage during ischemia.
Hypoxia-ischemia and nitric oxide during the perinatal period
During pregnancy, c NO biosynthesis increases in rats [239] and humans [240] , possibly contributing to maternal vasodilation and uterine immune suppression during this period. The rat placenta is another site of c NO biosynthesis because both constitutive and inducible NOS occur in this tissue [239^241]. However, the pathophysiological relevance of this observation remains to be determined. Despite this, a potential role for c NO in brain development has been advanced. Thus, in the embryonic central nervous system, nNOS would be expressed transiently in neurons [242, 243] and in brain blood vessels [244] , and would normally precede synaptogenesis, suggesting that c NO would mediate the formation of synaptic connections during development [245] . Interestingly, there seems to be a di¡erent pattern in brain NOS expression between precocious and non-precocious species. Regarding this issue, in the rat (a nonprecocious species), brain NOS activity mainly develops postnatally [246] , reaching adult levels at about 2 weeks after birth and rising to 150 or 130% of adult activity in the forebrain and cerebellum, respectively [247] . However, in the guinea pig (a precocious species), brain NOS activity (predominantly Ca 2 -dependent) reaches adult levels before birth [247] . In both species, the increase in brain NOS activity immediately precedes synaptogenesis and seems to be mediated by estrogens [247] . Therefore, NOS activity develops according to the pattern of brain maturation, suggesting an important role for c NO in brain development and function.
9.1.
c NO mediates brain damage in perinatal asphyxia
Regardless of the potentially relevant role of c NO in normal physiological brain development and function, a number of studies have linked excessive biosynthesis of this free radical to perinatal hypoxic-ischemic neurodegeneration. In this context, inhibiting NOS in vivo in 7-day-old rats protects them against hypoxic-ischemic-mediated neurotoxicity [91, 93, 248] ; the number of nNOS-containing neurons increases in the early phase of neonatal rat hypoxic-ischemic brain injury [51] and treatment with quisqualate, which selectively destroys nNOS-containing neurons, protects neonatal rats against hypoxia-ischemia [249] . Furthermore, brain mitochondrial damage during early neonatal anoxia is prevented by L-NAME treatment of the mothers [235] . Despite this evidence, con£icting hypotheses have also been suggested. For instance, synaptosomes isolated from neonatal rat brain did not show altered c NO synthesis or antioxidant status after in vitro hypoxia [250] . Likewise, it has been observed that neither cytosolic nor membrane bound NOS activity are a¡ected in cortical tissue in an in vivo model of hypoxia in the newborn piglet [52] . Whether increased oxidative stress and decreased antioxidant status [216] play relevant roles in c NO-mediated brain damage after hypoxic-ischemic insult during the perinatal period remains to be elucidated.
Excitotoxicity and perinatal ischemic brain damage
The immature brain is particularly susceptible to excessive release of the excitatory amino acids glutamate and aspartate [251] . In fact, the proportion of the glutamate-receptor subtype, NMDA, in both the immature rat brain cortex and the developing human brain is much greater than that observed in the adult brains of the same species [252] . Activation of this receptor is considered to be an important feature in the development of postischemic neuronal injury because the use of NMDA antagonists, such as MK-801, elicits neuroprotective e¡ects under a variety of experimental conditions [195,253^257] . Furthermore, the extracellular levels of excitatory amino acids increase several-fold during asphyctic insult to the cerebral cortex and striatum of fetal sheep [258] and to the cerebral cortex of the neonatal rat [259] , supporting the notion of increased perinatal vulnerability to excitatory amino acids.
Glutamate-receptor activation caused by presynaptic release of this excitatory amino acid after perinatal hypoxia-ischemia may initiate a cascade of biochemical e¡ects leading to neurotoxicity [260] . One possibility may involve nNOS activation and therefore c NO-mediated neuronal degeneration, as mentioned above. However, little is known about the exact mechanism of this toxicity. The production of cytokines, especially interleukin-1L, by the perinatal brain after NMDA injection has recently been suggested [261] . In fact, interleukin-1L mRNA expression increases transiently after ischemic, traumatic and excitotoxic brain injury [262^264] . Further experiments are necessary to fully establish whether enhancement of this cytokine has a neurotoxic or a neuroprotective role.
Therapeutic strategies
The expression of a novel endogenous NOS protein inhibitor induced by brain ischemia that participates in the prevention of CA1 hippocampal neurodegeneration [265] strongly supports the notion that NOS inhibitors, especially nNOS inhibitors, might o¡er a bene¢cial therapeutic strategy. Thus, several novel nNOS inhibitors have now been shown to prevent brain damage during ischemia, such as tirilazad [266, 267] , N-(S-methylisothioureido)-L-norvaline (L-MIN) [268] or ARL-17477 [269] . The inhibitor of glutamate release lubeluzole [270] , glutamate antagonists, such as lamotrigine [271] , antioxidants such as LY231617 [272] , a novel receptor ligand JO1784 [273] , immunosuppressants, such as FK506 [274, 275] , melatonin as a c NO and other free-radical scavenger [276] or a long-acting SOD derivative compound which increases c NO availability and improves cerebral blood blow [277] all potentially o¡er novel therapeutic strategies which should be taken into account in circumstances of brain hypoxic-ischemic neurodegeneration.
Concluding remarks
The increased c NO biosynthesis observed in the brain during hypoxic-ischemic insult seems to be a physiological response aimed at compensating the de¢ciency in oxygen and substrate for neural cells. Thus, endothelium-derived c NO produces smooth muscle relaxation and therefore vasodilation of the brain vessels, resulting in increased CBF to the infarcted brain area. Despite this mechanism, however, neuronally derived c NO during ischemia, possibly due to excitatory amino acid-mediated nNOS activation, may at the same time be neurotoxic, possibly because of the interference of c NO and/or ONOO 3 with energy metabolism, especially the mitochondrial respiratory chain and activation of energy-consuming DNA-repair pathways. The pathophysiological role of the delayed increase in iNOS expression observed in glial cells exposed to hypoxic-ischemic insult is still unclear. Whilst cytokines, which are able to induce iNOS expression, have been shown to be neuroprotective, recent evidence strongly suggests that iNOS expression in glial cells might be responsible for the toxicity observed after prolonged ischemia. Further work seems necessary to fully dissect the precise e¡ects of c NO, that depend on the time, sources and targets of c NO delivered during brain hypoxic-ischemic insult. Finally, selective nNOS inhibitors, which do not compromise endotheliummediated vasodilation, may o¡er a potential therapeutic strategy to prevent ischemic brain damage, although this is still a novel ¢eld and requires further study.
